Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Sectors Converge to Change the Future of Cancer in Urban Populations


News provided by

The Union for International Cancer Control (UICC)

17 Jan, 2017, 16:31 GMT

Share this article

Share toX

Share this article

Share toX

DAVOS, Switzerland, January 17, 2017 /PRNewswire/ --

  • New city-level initiative launched in partnership between the Union for International Cancer Control (UICC), the World Economic Forum and World Bank 
  • A commitment to saving lives by helping country and city leaders improve the health of their citizens and reduce inequities in access to quality cancer treatment and care 
  • A concrete response to the UN's global Sustainable Development Goals 3, 11 and 17 

A new initiative 'C/Can 2025: City Cancer Challenge' (C/Can 2025) was today launched at the World Economic Forum's Annual Meeting in Davos signalling a paradigm shift in the way international organisations will help country and city leaders address the growing burden of cancer they are facing.

The ambitious targets of the United Nations (UN) Sustainable Development Goals (SDGs) create a timely imperative to invest in non-communicable disease (NCD) treatment in cities, and specifically in cancer treatment.

Addressing SDGs 3 (Good health and wellbeing)[1], 11 (Sustainable cities and communities)[2] and 17 (Partnerships for the goals )[3], C/Can 2025 aims to increase the number of people with access to quality cancer treatment and care services in cities around the world with a population greater than 1 million.

This first-of-its-kind multisector initiative has been pioneered by the Union for International Cancer Control (UICC), in partnership with the World Economic Forum, the World Bank and others including city leaders, governments, NGOs, UN agencies, and domestic and international businesses.

With 1 in 3 people directly affected by cancer, the disease is one of the world's most pressing health concerns, killing over 8 million people per year, more than HIV/AIDS, malaria and TB combined.

Cancer is estimated to cost world economies as much as US$1.16 trillion annually[4] - a figure that is projected to grow exponentially if action is not taken now to reduce the spiralling growth in the number of cases and the impact on both individuals and healthcare budgets.

The greatest financial and human impact of cancer is felt within low- and middle-income countries (LMICs), those least equipped to respond to this growing burden, but also where rapid urbanisation is bringing significant public health and sustainable development challenges.

The global community has committed to reduce premature deaths from NCDs 25% by 2025[5] and by 33% by 2030, but to date, much of the effort to reduce mortality has focused on addressing shared risk factors for cancer and other NCDs.

This alone however is insufficient in being able to meet these global targets. With 54% of the world's population already living in cities, and that number expected to rise above 66% in the coming decades, C/Can 2025 has been conceived to address the urgent need to move political commitments made at the global level into fully functional, comprehensive cancer solutions, which can reach the majority of the world's population, therefore having a direct and concrete impact on cancer mortality rates and the target to reduce premature deaths by 2025.

In the first phase of the Challenge, C/Can 2025 will target select cities from LMICs where the need is greatest. These 'key learning cities' will provide insight on how the international community, local civil society and the public sector can best work together to implement the shared ambitions of C/Can 2025. The first three cities who have committed to the Challenge are: Asunción, Paraguay; Cali, Colombia; Yangon, Myanmar.

"This is a milestone for the health and development communities in that it is the first time such an international coalition of multisectoral organisations has been established to work with cities on improving cancer treatment and care," said Cary Adams, CEO of UICC. "This is a call to action for all sectors to support city governments with populations above 1 million to respond to the rising epidemic of cancer and show the world that, together, we can tackle this disease and save lives."

Arnaud Bernaert, Head of Global Heath and Healthcare at WEF reiterated this, "Partnering in initiatives like C/Can 2025 represent a powerful new force for global change. The World Economic Forum is supporting the innovative City Cancer Challenge because it convenes a unique set of stakeholders who are going to turn the tide on cancer in cities around the world."

Also speaking on the panel in Davos today were Michael Berkowitz, President of the Rockefeller Foundation's 100 Resilient Cities, Christoph Franz, Chairman of Roche and Edwin Macharia, Partner and Regional Director of Africa for Dalberg.

C/Can 2025 anticipates upwards of 80 cities being committed to the Challenge by the end of 2019 and that by 2025, when the UN measures progress against global NCD targets, the cancer community will be able to show how cities around the world are curing more cancer patients than ever before.

Founding partners of C/Can 2025 include: The World Economic Forum, World Bank, American Society of Clinical Oncology (ASCO), Icon Group, National Cancer Institute, US (NCI) and University of Pittsburgh Medical Centre (UPMC) and a coalition of 22 pharmaceutical companies.

Notes to the editor

About UICC

The Union for International Cancer Control (UICC) is the largest international cancer membership organisation in the world. It has more than 1,000 organisational members in 162 countries.

UICC is dedicated to taking the lead in convening, capacity building and advocacy initiatives that unite the cancer community to reduce the global cancer burden, promote greater equity, and integrate cancer control into the world health and development agenda.

Through UICC's UN Economic and Social Council (ECOSOC) status, UICC enjoys formal relationships with many UN agencies, including the World Health Organization (WHO), the International Agency for Research on Cancer (IARC), the International Atomic Energy Agency (IAEA) and others.

UICC has partners across all industry sectors and has access to the world's experts in practically every domain of cancer control. Over many years, UICC has earned a reputation for being an independent, objective voice for cancer control, willing and able to bring together parties committed to delivering global change through the implementation and scale-up of quality and sustainable programmes that address the global burden of cancer and other non-communicable diseases (NCDs).

UICC is a founding member of the NCD Alliance, a global civil society network that now represents almost 2,000 organisations in 170 countries.

--------------------------------------------------

1. SDG 3: Good health and well-being - Ensure healthy lives and promote well-being for all at all ages (Specifically, target 4 of goal 3 (3.4) which states: By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being)

2. SDG 11: Sustainable cities and communities - Make cities and human settlements inclusive, safe, resilient and sustainable

3. SDG 17: Partnerships for the goals - Strengthen the means of implementation and revitalize the global partnership for sustainable development

4. http://www.who.int/gho/publications/mdgs-sdgs/MDGs-SDGs2015_chapter6_snapshot_cancer.pdf?ua=1

5. Global Action Plan for the Prevention and Control of NCDs 2013-2020 http://www.who.int/nmh/events/ncd_action_plan/en/

For more information, please visit http://www.uicc.org/CCan2025
Follow @UICC #CCan2025 on Twitter

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.